Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Receivables (2017 - 2025)

Neuronetics (STIM) has disclosed Change in Receivables for 9 consecutive years, with -$2.2 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 1915.89% to -$2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.5 million through Dec 2025, down 195.01% year-over-year, with the annual reading at -$3.5 million for FY2025, 195.01% down from the prior year.
  • Change in Receivables for Q4 2025 was -$2.2 million at Neuronetics, up from -$3.9 million in the prior quarter.
  • The five-year high for Change in Receivables was $3.5 million in Q2 2022, with the low at -$3.9 million in Q3 2025.
  • Average Change in Receivables over 5 years is $974600.0, with a median of $809000.0 recorded in 2021.
  • The sharpest move saw Change in Receivables skyrocketed 369.8% in 2022, then plummeted 1915.89% in 2025.
  • Over 5 years, Change in Receivables stood at $720000.0 in 2021, then soared by 187.92% to $2.1 million in 2022, then crashed by 56.68% to $898000.0 in 2023, then tumbled by 111.92% to -$107000.0 in 2024, then tumbled by 1915.89% to -$2.2 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$2.2 million, -$3.9 million, and -$148000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.